
LINK . SPRINGER . COM {
}
Title:
Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice | Digestive Diseases and Sciences
Description:
Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Social Networks
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure how the site profits.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.
Keywords {🔍}
google, scholar, pubmed, article, cas, cancer, paclitaxel, gastric, nuclear, peritoneal, nfkappab, cell, fut, res, combination, human, pancreatic, inhibition, dissemination, intraperitoneal, activation, nafamostat, mesilate, group, carcinoma, antitumor, mice, inhibitor, apoptosis, cells, factor, enhances, uwagawa, access, chemotherapy, clin, privacy, cookies, content, haruki, fujiwara, furukawa, paclitaxelinduced, nfκb, study, vitro, resistance, taxol, oncol, factorkappab,
Topics {✒️}
paclitaxel-induced nuclear factor-kappa month download article/chapter inhibiting nf-κb activation paclitaxel-induced nf-κb activation nuclear factor-κb enhances tnf-alpha-induced apoptosis nuclear factor-kappab p65 ryota iwase & toya ohashi assessed nf-κb activity article digestive diseases gemcitabine-induced cell death constitutively active nf-kappab nuclear factor kappa nuclear factor-kappa nuclear factor-kappab nuclear factor kappab full article pdf enhanced anti-tumor therapy nf-kappab activation privacy choices/manage cookies cell growth regulation nf-κb inhibitor mediated cell death nf-kappab complexes nf-kappab antiapoptosis paclitaxel-induced apoptosis human breast cancer reveals cell cycle advanced gastric carcinoma pathological complete response breast cancer cells systemic combined chemotherapy intraperitoneal paclitaxel combined intraperitoneal antineoplastic agents suppress caspase-8 activation synthetic protease inhibitor taxol-induced polymerization inhibits lung metastasis taxol-induced apoptosis advanced gastric cancer anti-tumor effect established peritoneal dissemination check access instant access advanced pancreatic cancer rela transcription factor european economic area treating malignant tumors suboptimal therapeutic efficacy ikappabalpha super-repressor
Schema {🗺️}
WebPage:
mainEntity:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(169)
- How much money does https://www.springernature.com/gp/authors make?
- Revenue of https://link.springernature.com/home/
- How much does https://order.springer.com/public/cart net monthly?
- What's the income of https://submission.springernature.com/new-submission/10620/3?
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals generate monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=SEER%20cancer%20statistics%20review%2C%201975%E2%80%932000&publication_year=2003&author=Ries%2CL&author=Eisner%2CM&author=Kosary%2CC's earnings
- What's the profit of https://doi.org/10.1016%2FS0039-6060%2899%2970265-5?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10026754?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20vascular%20endothelial%20growth%20factor%20correlates%20with%20hematogenous%20recurrence%20in%20gastric%20carcinoma&journal=Surgery&doi=10.1016%2FS0039-6060%2899%2970265-5&volume=125&pages=195-201&publication_year=1999&author=Saito%2CH&author=Tsujitani%2CS&author=Kondo%2CA have monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9689986's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20Taxol%20in%20patients%20with%20advanced%20gastric%20carcinoma&journal=Cancer%20J%20Sci%20Am&volume=4&pages=269-274&publication_year=1998&author=Ajani%2CJA&author=Fairweather%2CJ&author=Dumas%2CP generate monthly?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7915154
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Update%20on%20the%20antitumor%20activity%20of%20pacitaxel%20in%20clinical%20trials&journal=Ann%20Pharmacother&volume=28&pages=S18-S22&publication_year=1994&author=Rowinsky%2CEK bring in?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17633066
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Cytoreduction%20and%20intraperitoneal%20chemotherapy%20for%20carcinomatosis%20from%20gastric%20cancer&journal=Cancer%20Treat%20Res&volume=134&pages=357-373&publication_year=2007&author=Yonemura%2CY&author=Bando%2CE&author=Kawamura%2CT?
- Earnings of https://doi.org/10.1093%2Fannonc%2Fmdp260
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19605503?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20weekly%20intravenous%20and%20intraperitoneal%20paclitaxel%20combined%20with%20S-1%20for%20advanced%20gastric%20cancer%20with%20peritoneal%20metastasis&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdp260&volume=21&pages=67-70&publication_year=2010&author=Ishigami%2CH&author=Kitayama%2CJ&author=Kaisaki%2CS
- What's the financial gain of https://doi.org/10.1056%2FNEJMoa052985?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16394300?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20cisplatin%20and%20paclitaxel%20in%20ovarian%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa052985&volume=354&pages=34-43&publication_year=2006&author=Armstrong%2CDK&author=Bundy%2CB&author=Wenzel%2CL?
- How much money does https://doi.org/10.1038%2Fsj.onc.1203768 make?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10962577?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20sensitivity%20of%20breast%20cancer%20cells%20with%20constitutively%20active%20NF-kappaB%20is%20enhanced%20by%20IkappaBalpha%20super-repressor%20and%20parthenolide&journal=Oncogene&doi=10.1038%2Fsj.onc.1203768&volume=19&pages=4159-4169&publication_year=2000&author=Patel%2CNM&author=Nozaki%2CS&author=Shortle%2CNH?
- What's the financial outcome of https://doi.org/10.1038%2Fsj.onc.1205848?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12226754
- How much does http://scholar.google.com/scholar_lookup?&title=The%20function%20of%20multiple%20IkappaB%3A%20NF-kappaB%20complexes%20in%20the%20resistance%20of%20cancer%20cells%20to%20Taxol-induced%20apoptosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1205848&volume=21&pages=6510-6519&publication_year=2002&author=Dong%2CQG&author=Sclabas%2CGM&author=Fujioka%2CS pull in?
- How much revenue does https://doi.org/10.1016%2FS0002-9440%2810%2961708-7 bring in?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11485895
- How much profit is http://scholar.google.com/scholar_lookup?&title=New%20insights%20into%20the%20role%20of%20nuclear%20factor-kappaB%20in%20cell%20growth%20regulation&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2961708-7&volume=159&pages=387-397&publication_year=2001&author=Chen%2CF&author=Castranova%2CV&author=Shi%2CX making per month?
- Monthly income for https://doi.org/10.1126%2Fscience.274.5288.782
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864118?
- How much income does http://scholar.google.com/scholar_lookup?&title=An%20essential%20role%20for%20NF-kappaB%20in%20preventing%20TNF-alpha-induced%20cell%20death&journal=Science&doi=10.1126%2Fscience.274.5288.782&volume=274&pages=782-784&publication_year=1996&author=Beg%2CAA&author=Baltimore%2CD have?
- What's the financial intake of https://doi.org/10.1126%2Fscience.274.5288.787?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864120 is on a monthly basis
- How profitable is http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20TNF-alpha-induced%20apoptosis%20by%20NF-kappaB&journal=Science&doi=10.1126%2Fscience.274.5288.787&volume=274&pages=787-789&publication_year=1996&author=Antwerp%2CDJ&author=Martin%2CSJ&author=Kafri%2CT?
- What is the monthly revenue of https://doi.org/10.1038%2Fni0302-221?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11875461 make?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20at%20the%20crossroads%20of%20life%20and%20death&journal=Nat%20Immunol&doi=10.1038%2Fni0302-221&volume=3&pages=221-227&publication_year=2002&author=Karin%2CM&author=Lin%2CA
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11751513?
- How much does http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20%28RelA%29%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20gastric%20carcinoma%20tissue&journal=Clin%20Cancer%20Res&volume=7&pages=4136-4142&publication_year=2001&author=Sasaki%2CN&author=Morisaki%2CT&author=Hashizume%2CK net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15154625 generate monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20is%20a%20prognostic%20indicator%20in%20gastric%20carcinoma&journal=Anticancer%20Res&volume=24&pages=1071-1075&publication_year=2004&author=Yamanaka%2CN&author=Sasaki%2CN&author=Tasaki%2CA
- What's the financial gain of https://doi.org/10.3748%2Fwjg.14.4739?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18720533
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor%20kappa%20B%3A%20a%20marker%20of%20chemotherapy%20for%20human%20stage%20IV%20gastric%20carcinoma&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.14.4739&volume=14&pages=4739-4744&publication_year=2008&author=Long%2CYM&author=Ye%2CS&author=Rong%2CJ is on a monthly basis
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9918209
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=The%20nuclear%20factor-kappa%20B%20RelA%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20pancreatic%20adenocarcinoma%20cells&journal=Clin%20Cancer%20Res&volume=5&pages=119-127&publication_year=1999&author=Wang%2CW&author=Abbruzzese%2CJL&author=Evans%2CDB is on a monthly basis
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12538487 make?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Function%20of%20nuclear%20factor%20kappaB%20in%20pancreatic%20cancer%20metastasis&journal=Clin%20Cancer%20Res&volume=9&pages=346-354&publication_year=2003&author=Fujioka%2CS&author=Sclabas%2CGM&author=Schmidt%2CC
- What's the monthly income of https://doi.org/10.1038%2F10577?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10202930
- How much does http://scholar.google.com/scholar_lookup?&title=Control%20of%20inducible%20chemoresistance%3A%20enhanced%20anti-tumor%20therapy%20through%20increased%20apoptosis%20by%20inhibition%20of%20NF-kappaB&journal=Nat%20Med&doi=10.1038%2F10577&volume=5&pages=412-417&publication_year=1999&author=Wang%2CCY&author=Cusack%2CJC&author=Liu%2CR generate monthly?
- Earnings of https://doi.org/10.1016%2FS0006-2952%2802%2900908-5
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11996883 produce monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Increase%20of%20the%20resistance%20of%20human%20cervical%20carcinoma%20cells%20to%20cisplatin%20by%20inhibition%20of%20the%20MEK%20to%20ERK%20signaling%20pathway%20partly%20via%20enhancement%20of%20anticancer%20drug-induced%20NF%20kappa%20B%20activation&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2802%2900908-5&volume=63&pages=1423-1430&publication_year=2002&author=Yeh%2CPY&author=Chuang%2CSE&author=Yeh%2CKH
- How much revenue does https://doi.org/10.1002%2Fijc.10972 bring in?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12584750
- How much income is http://scholar.google.com/scholar_lookup?&title=Disulfiram-mediated%20inhibition%20of%20NF-kappaB%20activity%20enhances%20cytotoxicity%20of%205-fluorouracil%20in%20human%20colorectal%20cancer%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10972&volume=104&pages=504-511&publication_year=2003&author=Wang%2CW&author=McLeod%2CHL&author=Cassidy%2CJ earning monthly?
- How much money does https://doi.org/10.1038%2Fsj.onc.1206390 make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12761494 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Role%20of%20NF-kappaB%20and%20Akt%2FPI3%C2%A0K%20in%20the%20resistance%20of%20pancreatic%20carcinoma%20cell%20lines%20against%20gemcitabine-induced%20cell%20death&journal=Oncogene&doi=10.1038%2Fsj.onc.1206390&volume=22&pages=3243-3251&publication_year=2003&author=Arlt%2CA&author=Gehrz%2CA&author=M%C3%BCerk%C3%B6ster%2CS generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11410792's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibitor%201%20enhances%20paclitaxel-induced%20apoptosis%20in%20human%20lung%20adenocarcinoma%20cell%20line&journal=Oncol%20Rep&volume=8&pages=825-829&publication_year=2001&author=Oyaizu%2CH&author=Adachi%2CY&author=Okumura%2CT pull in monthly?
- How much does https://doi.org/10.1016%2F0005-2744%2881%2990023-1 bring in each month?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6271224 make?
- How much does http://scholar.google.com/scholar_lookup?&title=New%20synthetic%20inhibitors%20of%20C1r%2C%20C1%20esterase%2C%20thrombin%2C%20plasmin%2C%20kallikrein%20and%20trypsin&journal=Biochim%20Biophys%20Acta&doi=10.1016%2F0005-2744%2881%2990023-1&volume=661&pages=342-345&publication_year=1981&author=Fujii%2CS&author=Hitomi%2CY rake in every month?
- How much does https://doi.org/10.1254%2Fjjp.35.203 net monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6482087's total income per month
- See how much http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamstat%20mesilate.%20I.%20Inhibition%20of%20protease%20activity%20in%20in%20vitro%20and%20in%20vivo%20experiments&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.35.203&volume=35&pages=203-227&publication_year=1984&author=Aoyama%2CT&author=Ino%2CY&author=Ozeki%2CM makes per month
- https://doi.org/10.1254%2Fjjp.41.155's financial summary
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2427760
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamostat%20mesilate.%20V.%20Effects%20on%20the%20pancreatic%20enzymes%20and%20experimental%20acute%20pancreatitis%20in%20rats&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.41.155&volume=41&pages=155-162&publication_year=1986&author=Iwaki%2CM&author=Ino%2CY&author=Motoyoshi%2CA bring in?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6667905?
- How much income is http://scholar.google.com/scholar_lookup?&title=Effects%20of%20FUT-175%2C%20a%20new%20synthetic%20protease%20inhibitor%20on%20endotoxin-induced%20disseminated%20intravascular%20coagulation%20in%20rats&journal=Haemostasis&volume=13&pages=374-378&publication_year=1983&author=Yoshikawa%2CT&author=Murakami%2CM&author=Furukawa%2CY earning monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1666354
- Income figures for http://scholar.google.com/scholar_lookup?&title=Nafamostat%20mesylate%20as%20anticoagulant%20in%20continuous%20hemofiltration%20and%20continuous%20hemodiafiltration&journal=Contrib%20Nephrol&volume=93&pages=215-217&publication_year=1991&author=Ohtake%2CY&author=Hirasawa%2CH&author=Sugai%2CT
- What are the earnings of https://doi.org/10.1002%2Fcncr.22658?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17410536 bring in each month?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20synthetic%20serine%20protease%20inhibitor%20%28FUT-175%29-mediated%20cell%20death&journal=Cancer&doi=10.1002%2Fcncr.22658&volume=109&pages=2142-2153&publication_year=2007&author=Uwagawa%2CT&author=Li%2CZ&author=Chang%2CZ each month?
- How much does https://doi.org/10.3892%2For.2010.843 gross monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20811662 generate?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Anti-tumor%20effect%20by%20inhibition%20of%20NF-kappaB%20activation%20using%20nafamostat%20mesilate%20for%20pancreatic%20cancer%20in%20a%20mouse%20model&journal=Oncol%20Rep&doi=10.3892%2For.2010.843&volume=24&pages=843-850&publication_year=2010&author=Furukawa%2CK&author=Iida%2CT&author=Shiba%2CH?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19661331
- Get to know http://scholar.google.com/scholar_lookup?&title=Combination%20chemotherapy%20of%20nafamostat%20mesilate%20with%20gemcitabine%20for%20pancreatic%20cancer%20targeting%20NF-kappaB%20activation&journal=Anticancer%20Res&volume=29&pages=3173-3178&publication_year=2009&author=Uwagawa%2CT&author=Chiao%2CPJ&author=Gocho%2CT's earnings
- What's https://doi.org/10.1093%2Fannonc%2Fmdn640's gross income?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18836085?
- http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20full-dose%20gemcitabine%20and%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn640&volume=20&pages=239-243&publication_year=2009&author=Uwagawa%2CT&author=Misawa%2CT&author=Sakamoto%2CT income
- What is the monthly revenue of https://doi.org/10.1097/COC.0b013e31823a53b2?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20gemcitabine%20in%20combination%20with%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Am%20J%20Clin%20Oncol&doi=10.1097%2FCOC.0b013e31823a53b2&publication_year=2011&author=Uwagawa%2CT&author=Misawa%2CT&author=Tsutsui%2CN have monthly?
- How much profit is https://doi.org/10.1097%2FMPA.0b013e31820b9257 making per month?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21343836
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Combination%20paclitaxel%20and%20inhibitor%20of%20nuclear%20factor%20%CE%BAB%20activation%20improves%20therapeutic%20outcome%20for%20model%20mice%20with%20peritoneal%20dissemination%20of%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2FMPA.0b013e31820b9257&volume=40&pages=600-607&publication_year=2011&author=Fujiwara%2CY&author=Furukawa%2CK&author=Shimada%2CY?
- Monthly income for https://doi.org/10.1016%2Fj.ab.2008.02.031
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18358228?
- Income figures for http://scholar.google.com/scholar_lookup?&title=A%20protocol%20for%20immunoaffinity%20separation%20of%20the%20accumulated%20ubiquitin-protein%20conjugates%20solubilized%20with%20sodium%20dodecyl%20sulfate&journal=Anal%20Biochem&doi=10.1016%2Fj.ab.2008.02.031&volume=377&pages=77-82&publication_year=2008&author=Shimada%2CY&author=Fukuda%2CT&author=Aoki%2CK
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6116707 makes per month
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Taxol-induced%20polymerization%20of%20purified%20tubulin%3A%20mechanism%20of%20action&journal=J%20Biol%20Chem&volume=256&pages=10435-10441&publication_year=1981&author=Kumar%2CN?
- How much cash flow does https://doi.org/10.1021%2Fbi00514a041 have monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6113842?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Taxol%20assembles%20tubulin%20in%20the%20absence%20of%20exogenous%20guanosine%205%E2%80%B2-triphosphate%20or%20microtubule-associated%20proteins&journal=Biochemistry&doi=10.1021%2Fbi00514a041&volume=20&pages=3247-3252&publication_year=1981&author=Schiff%2CPB&author=Horwitz%2CSB
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2898289
- How much profit is http://scholar.google.com/scholar_lookup?&title=Microtubule%20changes%20and%20cytotoxicity%20in%20leukemic%20cell%20lines%20treated%20with%20Taxol&journal=Cancer%20Res&volume=48&pages=4093-4100&publication_year=1988&author=Rowinsky%2CEK&author=Donehower%2CRC&author=Jones%2CRJ making per month?
- How much does https://doi.org/10.1038%2F277665a0 rake in every month?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=423966?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Promotion%20of%20microtubule%20assembly%20in%20vitro%20by%20Taxol&journal=Nature&doi=10.1038%2F277665a0&volume=277&pages=665-667&publication_year=1979&author=Schiff%2CPB&author=Faut%2CJ&author=Horwitz%2CSB?
- How much profit does https://doi.org/10.1016%2F0165-6147%2892%2990048-B generate?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1350385 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanism%20of%20action%20taxol&journal=Trends%20Pharmacol%20Sci&doi=10.1016%2F0165-6147%2892%2990048-B&volume=13&pages=134-136&publication_year=1992&author=Horwitz%2CSB make?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8849943
- Profit of http://scholar.google.com/scholar_lookup?&title=Peritoneal-plasma%20barrier&journal=Cancer%20Treat%20Res&doi=10.1007%2F978-1-4613-1247-5_4&volume=82&pages=53-63&publication_year=1996&author=Jacquet%2CP&author=Sugarbaker%2CPH
- Explore the financials of https://doi.org/10.1016%2FS0140-6736%2894%2990754-4
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7967989
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20taxoids%3A%20paclitaxel%20and%20docetaxel&journal=Lancet&doi=10.1016%2FS0140-6736%2894%2990754-4&volume=344&pages=1267-1272&publication_year=1994&author=Gelmon%2CK?
- How much cash flow does https://doi.org/10.1016%2F0305-7372%2886%2990007-1 have monthly?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3545463
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20antineoplastic%20agents%20for%20tumors%20principally%20confined%20to%20the%20peritoneal%20cavity&journal=Cancer%20Treat%20Rev&doi=10.1016%2F0305-7372%2886%2990007-1&volume=13&pages=219-242&publication_year=1986&author=Markman%2CM?
- How much does https://doi.org/10.1002%2F%28SICI%291097-0142%2819960101%2977%3A1%3C14%3A%3AAID-CNCR4%3E3.0.CO%3B2-N net monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8630921?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Paclitaxel-induced%20apoptosis%20in%20human%20gastric%20carcinoma%20cell%20lines&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2819960101%2977%3A1%3C14%3A%3AAID-CNCR4%3E3.0.CO%3B2-N&volume=77&pages=14-18&publication_year=1996&author=Chang%2CYF&author=Li%2CLL&author=Wu%2CCW
- How much profit is https://doi.org/10.1126%2Fscience.281.5383.1680 making per month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9733516 make?
- See how much http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20antiapoptosis%3A%20induction%20of%20TRAF1%20and%20TRAF2%20and%20c-IAP1%20and%20c-IAP2%20to%20suppress%20caspase-8%20activation&journal=Science&doi=10.1126%2Fscience.281.5383.1680&volume=281&pages=1680-1683&publication_year=1998&author=Wang%2CCY&author=Mayo%2CMW&author=Korneluk%2CRG makes per month
- How much income is https://doi.org/10.1158%2F1078-0432.CCR-04-0958 earning monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15569997?
- How much income does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20inhibitor%20of%20nuclear%20factor-kappaB%20phosphorylation%20increases%20the%20efficacy%20of%20paclitaxel%20in%20in%20vitro%20and%20in%20vivo%20ovarian%20cancer%20models&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-0958&volume=10&pages=7645-7654&publication_year=2004&author=Mabuchi%2CS&author=Ohmichi%2CM&author=Nishio%2CY have?
- Get to know https://doi.org/10.1158%2F1078-0432.CCR-05-1192's earnings
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16243823 generate?
- How much income is http://scholar.google.com/scholar_lookup?&title=Curcumin%20suppresses%20the%20paclitaxel-induced%20nuclear%20factor-kappaB%20pathway%20in%20breast%20cancer%20cells%20and%20inhibits%20lung%20metastasis%20of%20human%20breast%20cancer%20in%20nude%20mice&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-1192&volume=11&pages=7490-7498&publication_year=2005&author=Aggarwal%2CBB&author=Shishodia%2CS&author=Takada%2CY earning monthly?
- Revenue of https://doi.org/10.1002%2Fijc.23867
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18798274
- Earnings of http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20administration%20of%20a%20small%20interfering%20RNA%20targeting%20nuclear%20factor-kappa%20B%20with%20paclitaxel%20successfully%20prolongs%20the%20survival%20of%20xenograft%20model%20mice%20with%20peritoneal%20metastasis%20of%20gastric%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.23867&volume=123&pages=2696-2701&publication_year=2008&author=Inoue%2CM&author=Matsumoto%2CS&author=Saito%2CH
- How much income does https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=references have?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koichiro%20Haruki's financial summary
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koichiro%20Haruki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroaki%20Shiba?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroaki%20Shiba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Fujiwara
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Fujiwara%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenei%20Furukawa?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenei%20Furukawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ryota%20Iwase income
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ryota%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tadashi%20Uwagawa?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tadashi%20Uwagawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takeyuki%20Misawa pull in?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takeyuki%20Misawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toya%20Ohashi produce monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toya%20Ohashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katsuhiko%20Yanaga
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katsuhiko%20Yanaga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- What's https://s100.copyright.com/AppDispatchServlet?title=Inhibition%20of%20Nuclear%20Factor-%CE%BAB%20Enhances%20the%20Antitumor%20Effect%20of%20Paclitaxel%20Against%20Gastric%20Cancer%20with%20Peritoneal%20Dissemination%20in%20Mice&author=Koichiro%20Haruki%20et%20al&contentID=10.1007%2Fs10620-012-2311-4©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0163-2116&publicationDate=2012-07-18&publisherName=SpringerNature&orderBeanReset=true's gross income?
- What's https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=citation's gross income?
- What's https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's gross income?
- How profitable is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- What's the profit of https://www.springernature.com/gp/products?
- How much revenue does https://www.springernature.com/gp/librarians produce monthly?
- Discover the revenue of https://www.springernature.com/gp/societies
- How much revenue does https://www.springernature.com/gp/partners produce monthly?
- Get to know what's the income of https://www.springer.com/
- Check the income stats for https://www.nature.com/
- How much revenue does https://www.biomedcentral.com/ generate?
- What's the financial intake of https://www.palgrave.com/?
- https://www.apress.com/'s revenue stream
- What's the monthly income of https://www.springernature.com/gp/legal/ccpa?
- How much does https://www.springernature.com/gp/info/accessibility generate monthly?
- Get to know https://support.springernature.com/en/support/home's earnings
- What's the income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- See how much https://www.springernature.com/ makes per month
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref